| University of Manchester 2020. Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors. US 10570157. [Patent]. |
Preview |
PDF
- Published Version
Download (4MB) | Preview |
Official URL: https://patents.google.com/patent/WO2017017469A1/e...
Abstract
Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 .beta. activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.
| Item Type: | Patent |
|---|---|
| Date Type: | Published Online |
| Status: | Published |
| Schools: | Schools > Biosciences |
| Publisher: | US Patent |
| Date of First Compliant Deposit: | 18 May 2020 |
| Date of Acceptance: | 25 February 2020 |
| Last Modified: | 07 Nov 2022 10:17 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/131765 |
Actions (repository staff only)
 |
Edit Item |
Download Statistics
Download Statistics